CVV on Nasdaq
CVD EQUIPMENT CORP
Price unavailable
Last updated Oct 16, 2026.
Overview
Compare with GREYSTONE LOGISTICS, INC., SONO TEK CORP or Velo3D, Inc., or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Industrial brought in 45% of the revenue CVD EQUIPMENT CORP broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2024 | 2025 |
|---|---|---|
| Industrial | $8.3M | $11.6M |
| Aerospace | $13.1M | $8.0M |
| Research | $4.8M | $6.2M |
| Energy | $727.0K | $87.0K |
| Cargo and Freight | $73.0K | $48.0K |
Business segments
CVD brought in 69% of the revenue CVD EQUIPMENT CORP broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2024 | 2025 |
|---|---|---|
| CVD | $18.3M | $18.1M |
| SDC | $8.4M | $7.9M |
| Meso Scribe Technologies Inc | $778.0K | $112.0K |
Regions
Americas brought in 95% of the revenue CVD EQUIPMENT CORP broke down this way in fiscal 2025.
Regions by year
| Regions | 2024 | 2025 |
|---|---|---|
| Americas | $25.7M | $24.4M |
| EMEA | $521.0K | $819.0K |
| Asia Pacific | $570.0K | $567.0K |
| North America | $65.0K | $7.0K |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue72¢$18.5M
- Research and development11¢$2.8M
- Other costs17¢$4.5M
- Income tax0¢$3.0K
Out of $25.8M in revenue.3 The company lost money this year.
Financial statements
Every line of the income statement in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenue | $25.8M | $26.9M |
| Cost of revenue | $18.5M | $20.8M |
| Gross profit | $7.3M | $6.1M |
| Research and development | $2.8M | $2.6M |
| Selling | $1.4M | $1.7M |
| General and administrative | $4.8M | $4.9M |
| Impairment charges | $163.0K | |
| Gains on sales of equipment | -$717.0K | |
| Total operating expenses, net | $9.2M | $8.5M |
| Operating loss | -$1.9M | -$2.4M |
| Interest income | $341.0K | $559.0K |
| Interest expense | -$13.0K | -$19.0K |
| Other income | $2.0K | |
| Total other income, net | $328.0K | $542.0K |
| Loss before income tax | -$1.6M | -$1.9M |
| Income tax expense | $3.0K | $24.0K |
| Net loss | -$1.6M | -$1.9M |
| Basic | -$0.23 | -$0.28 |
| Diluted | -$0.23 | -$0.28 |
| Basic | 6.9M shares | 6.8M shares |
| Diluted | 6.9M shares | 6.8M shares |
Every line of the balance sheet in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $8.7M | $12.6M | |
| Accounts receivable, net of allowance for credit losses | $2.3M | $2.1M | |
| Contract assets | $3.4M | $2.2M | |
| Inventories | $1.6M | $2.1M | |
| Assets held for sale | $510.0K | ||
| Other current assets | $367.0K | $898.0K | |
| Total current assets | $16.9M | $20.0M | |
| Property, plant and equipment, net | $10.6M | $11.7M | |
| Other assets | $52.0K | $1.0K | |
| Total assets | $27.5M | $31.7M | |
| Accounts payable | $642.0K | $679.0K | |
| Accrued expenses | $1.2M | $2.2M | |
| Current maturities of long-term debt | $181.0K | $87.0K | |
| Contract liabilities | $773.0K | $3.1M | $4.9M |
| Total current liabilities | $2.8M | $6.1M | |
| Long-term debt, net of current portion | $181.0K | ||
| Total liabilities | $2.8M | $6.3M | |
| Common stock - $0.01 par value 20,000,000 shares authorized; issued and outstanding 6,937,338 at December 31, 2025 and 6,881,838 at December 31, 2024 | $69.0K | $69.0K | |
| Additional paid-in capital | $30.7M | $29.8M | |
| Accumulated deficit | -$6.0M | -$4.5M | |
| Total stockholders equity | $24.7M | $25.4M | $26.2M |
| Total liabilities and stockholders equity | $27.5M | $31.7M | |
| Common stock, par value | $0.01 | $0.01 | |
| Common stock, shares authorized | 20.0M shares | 20.0M shares | |
| Common stock, shares issued | 6.9M shares | 6.9M shares | |
| Common stock, shares outstanding | 6.9M shares | 6.9M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net loss | -$1.6M | -$1.9M |
| Stock-based compensation | $942.0K | $1.1M |
| Depreciation and amortization | $683.0K | $684.0K |
| Provision for excess and obsolete inventory | $1.6M | |
| Provision (recovery) for bad debt | -$18.0K | $13.0K |
| Impairment charges | $163.0K | |
| Gains on sales of equipment | -$717.0K | |
| Accounts receivable | -$147.0K | -$256.0K |
| Contract assets | -$1.2M | -$622.0K |
| Inventories | $365.0K | $646.0K |
| Other assets | $530.0K | -$150.0K |
| Accounts payable | -$37.0K | -$524.0K |
| Accrued expenses | -$1.0M | $472.0K |
| Contract liabilities | -$2.4M | -$1.8M |
| Net cash used in operating activities | -$3.7M | -$1.5M |
| Purchase of property and equipment | -$48.0K | -$106.0K |
| Investment in captive insurance company | -$51.0K | |
| Net proceeds from sales of equipment | $250.0K | |
| Net cash (used in) provided by investing activities | -$99.0K | $144.0K |
| Payments of long-term debt | -$87.0K | -$82.0K |
| Net cash used in financing activities | -$87.0K | -$82.0K |
| Net decrease in cash and cash equivalents | -$3.9M | -$1.4M |
| Income taxes paid | $27.0K | $3.0K |
| Interest paid | $13.0K | $19.0K |
| Property, plant and equipment transferred to assets held for sale | $633.0K | |
| Inventory transferred to property, plant and equipment | $181.0K | $110.0K |
Recent filings
- Sep 25, 2026DEF 14A
- Sep 10, 20268-K
- Aug 12, 20268-K
- Aug 12, 202610-Q
- May 28, 2026SD
- May 14, 20268-K
- May 14, 202610-Q
- Apr 7, 20268-K
- Mar 30, 20268-K
- Mar 30, 202610-K
- Mar 24, 20268-K
- Jan 21, 2026SCHEDULE 13G/A
- Nov 10, 20258-K
- Nov 10, 202510-Q
- Aug 12, 20254
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10